Navigation Links
New gateway to treat leukemia and other cancers
Date:3/25/2010

This press release is available in French.

Montreal, March 25, 2010 Canadian researchers have discovered a previously hidden channel to attack leukemia and other cancer cells, according to a new study published in the Journal of Biological Chemistry. The findings from the Universit de Montral, Maisonneuve-Rosemont Hospital and Universit Laval may change the way doctors treat cancer patients.

"We found a gateway, which is present in all humans, that allows anti-cancer agents such as Bleomycin to enter the body so they may reach and attack leukemia cells," says senior author Dindial Ramotar, a professor at the Universit de Montral Faculty of Medicine and a scientist at the affiliated Maisonneuve-Rosemont Hospital.

Dr. Ramotar began testing his theory a full decade ago using baker's yeast, which is remarkably similar to human cells. "Our discovery went from that model system to human cells and will soon reach the bedside through translational therapy," he explains. "We are on the brink of testing patients."

The new gateway (SLC22A16) may be a lifesaver for patients with acute myeloid leukemia (AML), a cancer that affects white blood cells. AML patients are extremely difficult to treat, since most are unresponsive to anticancer remedies. "We can now streamline anti-cancer agents to treat AML," says Dr. Ramotar. "For example, we found the anti-cancer agent Bleomycin has positive results on lymphoma cells derived from patients and depends on the presence of the gateway. That's especially good news, since Bleomycin does not act as an immunosuppressant."

The newly identified gateway, Dr. Ramotar cautions, is only "present in some cell types such as those derived from bone marrow." The channel also does not function in colon and breast cancer making it difficult to treat these patients with Bleomycin, he adds. "We must now examine ways to stimulate the gateway to treat a broad range of cancers using Bleomycin and other drugs."


'/>"/>

Contact: Sylvain-Jacques Desjardins
sylvain-jacques.desjardins@umontreal.ca
514-343-7593
University of Montreal
Source:Eurekalert

Related medicine news :

1. BMEGateway Celebrates its 20th Anniversary and Welcomes Dr. William Morgan
2. Technology new gateway into treatment for problem alcohol users: Study
3. Djigzo, an Open Source Email Encryption Provider, Today Announced That the Company's Encryption Gateway Now Supports Red Hat Linux
4. Michigan Health Care Providers Select mPay Gateways Point-of-Care Patient Payment System
5. GateWay Community College Receives Strong Endorsement for Re-accreditation
6. Steroids May Be Overrated in Treatment of COPD
7. Untreated, Mild May Become Major Depression
8. Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security
9. Experimental stem cell treatment arrests acute lung injury in mice, study shows
10. American Association of Poison Control Centers: Treat Poinsettias and Mistletoe with Respect Rather Than Fear This Holiday Season
11. Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... Dermatologic surgeons performed nearly 10 million medically necessary ... percent since 2012. , The results of the 2015 ASDS Survey on Dermatologic Procedures ... cancer treatments and the growing popularity of soft-tissue fillers and body sculpting procedures. ...
(Date:5/5/2016)... ... May 05, 2016 , ... MAP Health Management, LLC, ... that Enlightened Solutions has joined the Premier Outcomes-Driven Provider Network. By becoming a ... their patients being treated for substance use. , Enlightened Solutions was founded by ...
(Date:5/5/2016)... ... 05, 2016 , ... Liposuction specialist Marcia V. Byrd, MD spoke last month ... the Marriot St. Louis Airport Hotel. This year’s conference was titled “Living with Lipedema ... her unique specialization in treating Lipedema. Dr. Byrd is considered one of the leading ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... Nepenthe Laboratory ... Riverbend Elementary School last week to raise non-perishable food item donations for Food for ... Nose Day” hosted on NBC. , “The goal of the assembly was to create ...
(Date:5/5/2016)... , ... May 05, 2016 , ... Augusta Public Schools ... school nurses. This partnership will enable school health offices to streamline and bolster care ... County, Kansas, just east of Wichita. Augusta public schools serve 2,300 students among its ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... CITY, Mo. , May 3, 2016 /PRNewswire/ ... Kansas Medical Center,s Institute for Advancing Medical Innovation ... and commercialize new drugs, diagnostics and medical devices. ... provides BioNovus Innovations with rights to license, develop ... "This partnership represents ...
(Date:5/3/2016)... 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further expand product development, strengthen its ... http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
(Date:5/3/2016)... 2016 ACME Markets, ... Delaware County Councilman Dave White ... all ACME pharmacies across Delaware ... and Prevention (CDC), naloxone has saved 26,463 lives nationwide over the ... Delaware County were authorized to administer naloxone to ...
Breaking Medicine Technology: